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Background/aim: Altered iron metabolism is one of the pathophysiological mechanisms occurring during hypoxic injuries in the
central nervous system. Proper homeostasis of cellular iron is regulated by iron import, storage, and export proteins that prevent excess
iron overload or iron starvation in cells. Therapeutic hypothermia is an approved treatment for hypoxic ischemia in newborns, but
the underlying molecular mechanism is still unknown. We studied the effects of hypoxia, preceded with preconditioning, on the iron
homeostasis of glial cells, known as a major actor in the inflammatory process during perinatal brain injury.
Materials and methods: Primary microglia and astrocytes in culture were exposed to 12 h of hypoxia with or without mild hypothermic
preconditioning. The mRNA expression was assessed using qPCR. Iron accumulation was visualized via modified Perl’s histochemistry.
Cytokine levels in cell cultures were measured using ELISA.
Results: Hypothermic preconditioning enhanced microglial viability, which previously was decreased in both cell types due to hypoxia.
Hypoxia increased iron accumulation in the mixed glial cells and in ferritin expression in both microglia and astrocytes. Hypotermic
preconditioning decreased the elevated ferritin-light chain expression significantly in microglia. Iron importer proteins, DMT1 and
TfR1, both increased their mRNA expression after hypoxia, and hypothermic preconditioning continued to support the elevation of
DMT1 in both glial cell types. Ferroportin expression increased as a survival factor of the glial cell following hypoxia. Hypothermic
preconditioning supported this increase in both cell types and was especially significant in astrocytes. IL-10 levels were prominently
increased in cell culture after hypothermic preconditioning.
Conclusion: The data suggest that hypothermic preconditioning affects cellular iron homeostasis by regulating the storage and transfer
proteins of iron. Regulation of the cellular iron traffic may prevent glial cells from experiencing the detrimental effects of hypoxia-related
inflammation.
Key words: Hypoxic brain injury, glia, iron, ferritin, hypothermia, preconditioning

1. Introduction
Motor or cognitive neurological disorders originating from
the perinatal period pose an increasingly serious health
problem in developing countries [1]. Hypoxic ischemic
(HI) conditions are the main cause of brain damage in
newborns. Oxygen deprivation is seen in many childhood
diseases such as obstructive sleep apnea, bronchopulmonary
dysplasia, congenital heart diseases, asthma, epilepsy, and
sickle cell anemia, as well as in nonprogressive but longterm cognitive and/or motor disorders [2].
In addition to the impaired cerebral blood flow
associated with hypoxia-reperfusion injury, several

intracellular pathways triggered by excessive inflammation
also play a role in the pathogenesis of brain white matter
lesions in newborns [3]. Astrocytes and microglia are
the main determinants of this inflammatory process [4].
The excessive gliosis that occurs in the hypoxic brain
injury process can lead to the development of tertiary
brain damage, and microglial signaling may induce the
cytotoxicity of astrocytes. In contrast, a controlled regular
microglial response can speed up the regeneration process
[5]. Another feature of hypoxic injury is that the damage
is progressive and moves forward to solid tissue within
days/weeks. Although the mechanism of this spread is not
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fully explained, glial cells are known to play a role via ‘gap
junctions’ [4].
Iron is a key player in brain development in the fetal
and early neonatal period. Excessive accumulation of iron
causes iron-mediated free radical damage within the cell.
On the other hand, iron is necessary for the activity of
many metabolic enzymes and thus critical for maintaining
cell viability [6]. Proper functioning of mechanisms
controlling cellular iron levels through various transport
and storage proteins is responsible for maintaining
intracellular iron homeostasis. Studies in infants and
neonatal rats have shown that hypoxic-ischemic damage
increases free iron levels in serum and cerebrospinal fluid
[7]. Accumulated iron, which is associated with hypoxia
at the cellular level, especially in microglia, stimulates
reactive oxygen products, cytokine production, and
the resultant apoptosis of oligondendrocytes. Microglia
prevents excessive iron accumulation in the environment
by binding it following hypoxic damage [8]. It has been
suggested that excessive iron retained in microglia may
be a regulator for oligodendrocyte cytotoxicity seen
in periventricular white matter following hypoxia [9].
Hypoxic damage in the brain enables activation of a
transcription complex, hypoxia-inducible factor 1 subunit
alpha (HIF-1a), resulting in the activation of many genes
that allows cells to adapt to hypoxia and thus recover from
cell death [10]. Transferrin receptor (TfR)1 and divalent
methyl carrier (DMT)1, proteins involved in cellular
iron transport are regulated with expression of HIF-1a in
neurons, astrocytes, [11] and microglia [12].
Containing heavy and light chain, ferritin is directly
affected by hypoxia in terms of both cellular distribution
and subcortical white matter myelinization pattern. Brain
damage that develops in the neonatal rat brain mediated
by HI results in increased ferritin-positive microglial
cells in the environment. In the hypoxia and subsequent
reoxygenation process, glial ferritin increases in the
early period, while neuronal ferritin increases in the late
stages of reoxygenation. Ferritin expression is indirectly
regulated by other factors such as HIF-1a during hypoxiareoxygenation. Changes in iron homeostasis in cortical
and glial cells during an experimental ischemia process
are considered to be part of the adaptive response of cells
to hypoxia [13].
Preconditioning processes can be protective in both
experimental and human studies [14]. Studies have shown
that HIF-1a and its target genes are involved in hypoxic
preconditioning-induced neuroprotection. In addition,
the adaptation of cells and tissues to hypoxia induce
many gene transcriptions involved in iron metabolism.
In multicenter controlled studies, exposure of low or
moderate hypothermia in encephalopathic newborns has
also been shown to significantly suppress the development
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of hypoxic damage [15,16]. The molecular mechanisms
underlying hypothermia-generated neuroprotective effects
have not yet been fully clarified. It has been shown that
hypothermia and subsequent reheating cause activation
in microglia, increases phagocytosis, and changes the
cytokine balance in favor of antiinflammatory cytokines
[17]. Hypothermia may also be protective by controlling
the inflammatory process via suppressing interferon (IFN)
beta and nitric oxide (NO) [18].
In this study, the mechanism of action of hypothermia
on iron storage and transport proteins that regulate iron
homeostasis were investigated in primary astrocyte and
microglia cell culture in mice.
2. Materials and methods
2.1. Primary cell culture
Glial cell cultures were prepared as described previously
[19]. Briefly, the neonatal mouse cerebral cortex was
dissociated and plated in tissue-culture flasks. Ten days
later the confluent cells were treated for mixed glial cell
culture group. Another group of cells were treated for
5 min with mild trypsinization (% trypsin with 0.25
mM EDTA), which detached a layer of loosely adherent
cells, most of which being mainly astrocytes. This left
behind firmly adherent cells, which are >90% microglia.
Afterward, the cells were cultured for 5 days in DMEM/
F12 culture medium containing 10% FBS, 1% penicillin/
streptomycin, and 1% vitamins mixed 1:1 with mixed glial
cell-conditioned media before stimulation. For astrocytes,
a 3rd group of confluent cells were left at 37 °C overnight
in a horizontal shaker (200 rpm) with paraffine closed
lids, and then the floating cells were discarded. After a
mild trypsinization, cells were replated at 1/3 the density
in DMEM culture medium containing 10% FBS, 1%
penicillin/streptomycin, and 1% vitamins. Cells were ready
to use after a 7-day mitotic inhibitor cytosine arabinoside
(10 IM) treatment to remove proliferating meningeal cells.
The purity of astrocyte and microglia cultures was assessed
by immunofluorescence labeling for GFAP and CD11b,
respectively. Purified microglia were plated at a density of
8 × 105 cells/well, and purified astrocytes were plated in
fresh media at a density of 5 × 105 cells/well 2 days before
the start of the experiment. Throughout the experiment,
different and newly prepared—but always confluent—cell
cultures were used at each time point and condition.
2.2. Hypoxia induction and hypothermic preconditioning
Hypoxia induction was performed using a chamber
(Stemcell Technologies Inc., Canada) containing 94%
N2, 5% CO2, and 1% O2 as previously described in the
literature [12,20] (n = 3 per group, duplicated, pooled
from 6 animals for each cell type). During hypoxia and
ischemic conditions neither oxygen nor glucose can reach
the tissues, so we applied oxygen-glucose deprivation
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as a closer in vitro model to in vivo. To reach that goal,
we incubated the cells in PBS during the experimental
procedure. After draining the chamber and filling it with
the desired concentration of gas, it was locked and left
in the 37 °C incubator with the normoxic control plates.
Hypoxia induction was confirmed using the increased
expression of HIF-1a, using qPCR as described below. Cell
viability was tested with the colorimetric method based on
the tetrazolium salt XTT at 2, 6, 12, and 24 h (Biological
Industries, Israel). Cytotoxicity was accepted as occurring
when more than 50% of the cells in culture had died. HP
was performed by incubating the cells at 33 °C for 20
min as previously indicated as mild hypothermia in the
literature [21].
2.3. Perl’s histochemistry
Cellular iron accumulation was shown using modified Perl’s
histochemistry as previously described in literature [22].
Briefly, cells were plated to PLL coated glass coverslips and
left in hypoxic conditions as described above. Coverslips
were then fixed with 4% paraformaldehyde for 15 min
in the wells. After washing with PBS, the coverslips were
first incubated in 4% potassiumferricyanide, and then in a
mixture of 4% HCl and 4% potassiumferricyanide for 1 h.
Cells stored in iron became visible with a serial incubation
with diaminobenzidin (DAB) (Amresco, USA) and 30%
H2O2. Stained coverslips were fixed before visualization
with a light microscope.
2.4. Quantitative real time polymerase chain reaction
(q-PCR)
After hypoxic incubation with or without HP, cells were
harvested using β-merkaptoetanol-added lysis solution
and stored at –80 °C until RNA extraction (n = 3 per group,
duplicated, pooled from 6 animals for each cell type). Total
RNA was extracted using an RNeasy Mini Kit (Qiagen,
USA) following the manufacturer’s instructions. cDNA
was reverse transcribed with an Omniscript Kit (Qiagen,
USA) and was amplified in an Abi OneStep Cycler (Applied
Biosystems, CA, USA) using specific primer pairs for
ferritin heavy (-H) and light (-L) chains, ferroportin (Fpn),
transferrin receptor (TfR)1, and divalent metal transporter

1 (DMT1). Peptidylprolyl isomerase A (PPIA) was used as
an internal control gene. The results were quantified using
the ΔΔCT method following standardization relative to the
internal control gene [23]. Primers are listed in the Table.
2.5. Immunofluorescence staining
Cells were plated on poly-L-Lysine-coated round glass
coverslips and allowed to attach for 24 h in 24-well
plates. Each group was incubated in hypoxic conditions
with or without HP. Primary antibodies (CD11b: mouse
monoclonal IgG, Abcam, UK; GFAP: mouse monoclonal
IgG, Santa Cruz, USA; ferritin: rabbit polyclonal IgG,
Santa Cruz, USA) were used at 1:200, and the appropriate
secondary antibody (goat poly-IgG to rabbit and donkey
poly-IgG to mouse, Abcam, UK) conjugated with Alexa
Fluor 488, which was used at 1:400 dilution. Cells were
stained as described previously [19]. Briefly, after washing
with HBSS, the cells were incubated with the primary
antibody for 30 min, followed by washing and incubation
with the appropriate secondary antibody for 30 min.
For surface antigens such as CD11b, the cells were then
fixed with 95% ethanol and 5% acetic acid for 15 min at
4 °C. Intracellular antigens (GFAP, ferritin) required cell
permeabilization before incubation with the primary
antibody [24]. After washing in PBS, the coverslips were
mounted in antifade mounting medium containing
DAPI (Life Technologies, USA) and analyzed using a
fluorescence microscope.
2.6. ELISA
After hypoxic induction with or without HP, cell culture
supernatants were collected and stored at –80 °C until the
day of analysis. IL-6, TNF-alpha, and IL-10 levels were
measured using commercial ELISA kits following the
manufacturer’s instructions (Boster Biological Technology,
USA).
2.7. Statistical analysis
Statistics were preformed using SPSS v.20. Analyses were
performed with the Kruskal–Wallis test for multiple
comparisons and with the Mann–Whitney U test for pairs.
Differences were considered significant at P < 0.05. Data
were presented as mean ± SEM.

Table. Primer sequences were used for qPCR (fw/rv).
PPIA

CCCACCGTGTTCTTCGACAT / CCAGTGCTCAGAGCACGAAA

HIF-1a

TGATGTGGGTGCTGGTGTC / TGATGTGGGTGCTGGTGTC

Ferritin-H

TAAAGAACTGGGTGACCACGTGAC/ AAGTCAGCTTAGCTCTCATCACCG

Ferritin-L

TGGCCATGGAGAAGAACCTGAATC/ GCTTTCCAGGAAGTCACAGAGAT

TfR1

AGCAGCATCTGCTAATGAGACCCA/ TGCAAGCTTTGTCTTCCCAACAAC

DMT1

TGAATCGGGCCAATAAGCAGG/ ATCAGCAAAGACGGACACGACAA

Fpn

AGAGCTGACCTGGCACCTTA / GGCCCAAGTCAGTGAAGGTA
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3. Results
Mixed glial cell culture was incubated in hypoxic conditions
for 2, 6, 12, and 24 h. After checking cell proliferation
for mixed glial cells, 24 h of incubation was excluded
because more than 50% of the cells had died. Hypoxia
was confirmed by checking the expression of HIF-1a in
mixed glial cells with qPCR. Compared to the control,
HIF-1a expression did not change after 2 h of hypoxia (P
> 0.05) but was significantly elevated both after 6 and 12 h
of hypoxic conditions (P < 0.05). Based on this result, the
2-h incubation was removed from the time points as it did
not provide a successful hypoxia in mixed glial cell culture.
Iron accumulation due to hypoxia in mixed glial
cell culture was shown using Perl’s histochemistry.
Representative images showed iron accumulation within
glial cells in culture after 12 h of hypoxia but, in contrast,
very little staining was seen after 6 h of incubation (Figure
1a).
Ferritin-H and -L expression in hypoxic conditions
were elevated for both 6 and 12 h in hypoxic conditions in
mixed glial cell culture, but the increase was significant at
12 h (P < 0.05) (Figure 1b).
In mixed glial cell culture, regarding iron accumulation
displayed by modified Perl’s histochemistry and ferritin
expression detected by q-PCR, 12 h of hypoxia produced
significant changes compared to 6 h (P < 0.05). Based on
these results, subsequent single cell culture experiments
were performed with 12 h of hypoxia application for both
microglia and astrocyte.
To study the different roles of both glial cells in hypoxic
conditions with and without hypothermic conditioning,
primary astrocyte and microglia were isolated from
newborn pup brains (P2-4) and, following the cellspecific protocol, cultured for 2 extra days until the cells
got confluent. An XTT test was performed after hypoxia,
and both cell types showed a significant decrease in cell
numbers after 12 h of hypoxia (P < 0.05). Microglia counts
were observed as significantly increased after HP when
compared to both control and hypoxic conditions (P <
0.05) (Figure 2).
3.1. Changes in the expression of iron homeostasis
proteins in hypoxia with HP
3.1.1. Iron storage protein: ferritin
Cellular iron storage was shown by measuring ferritin
mRNA expression as heavy (-H) and light chain (-L).
In astrocytes, hypoxia increased both ferritin chain
expressions, being significant for the light chain (P < 0.05).
HP did not have any significant effect on ferritin expression
in astrocytes. Hypoxia significantly increased ferritin-L
and -H expression in microglia (P < 0.05). HP reduced the
expression of both chains, which were significantly lower
for ferritin-L (P < 0.05) (Figures 3a and 3b).

2008

The antibody used in ferritin immunofluorescence
staining did not determine the different chains, so pure
ferritin was stained in both microglia and in astrocytes
after hypoxia. Cells stained more comprehensively; they
were particularly weaker in microglia but still positive
after HP followed by hypoxia (Figure 3c).
3.1.2. Iron importers: DMT1 and Transferrin receptor
(TfR)1
Hypoxia definitely increased DMT1 mRNA expressions
both in microglia and the astrocytes (P < 0.05). DMT1
mRNA expression was significantly higher, especially after
HP (P < 0.01) in both cell types (Figures 4a and 4b). TfR1
mRNA expression after hypoxia was significantly elevated
in both microglia and in astrocytes with and without HP
(P < 0.05). HP did not make any significant difference on
TfR1 expression when compared to hypoxic conditions
(Figure 4c).
3.1.3. Iron exporter: ferroportin
Ferroportin mRNA expression increased in both cells
incubated in hypoxic conditions (P < 0.01). Compared
to the control group, HP increased ferroportin mRNA
expression significantly in astrocytes (P < 0.01) and
microglia (P < 0.05) but, compared to hypoxia, the
difference was significant only for astrocytes (P < 0.05)
(Figure 4d).
3.2. ELISA
TNF-alpha levels in both glial cell types and IL-6 levels in
astrocytes were under detection limits. When compared
to the control group, IL-10 levels significantly increased in
both cells after hypoxia (P < 0.05), and HP remained and
sustained this increase in both cells types, being significant
in microglia (Figures 5a and 5b). Microglial IL-6 levels
increased following hypoxia (P < 0.05); however, they were
not significantly affected by HP (Figure 5c).
4. Discussion
In this study, the response of glial cells, the key players
in the inflammatory responses generating in the brain
to HP before hypoxia, was investigated through ironrelated cellular storage and transport proteins. We provide
evidence that HP before hypoxia decreases the cytotoxicity
in microglia and suppresses the expression of the light
chain of ferritin specifically by altering the expression of
transport proteins; this may be beneficial by suppressing
the iron related detrimental effect following hypoxic injury.
Although various methods are applied for treatment
of HI encephalopathy, inflammatory cells and pathways
stimulated by the mechanisms of these treatments have
not been fully elucidated yet. In addition, since there
is no definite treatment for HI damage, so it is of great
importance to understand the molecular mechanisms of
pathogenesis, to identify specific markers for diagnosis in
order to minimize the level of degeneration, and to develop
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Figure 1. a) iron accumulation and b) ferritin-H and -L expression after 6 and 12 h
of hypoxia in mixed glial cell culture (n = 3) (data are shown as mean ± SEM) (#P
> 0.05, *P < 0.05; compared to control).

new treatment and rehabilitation options in addition to
prevention.
Therapeutic hypothermia is a neuroprotective strategy
that improves neurological outcomes after several
brain damage mechanisms, including hypoxic injury
[25]. In addition to neurons, all glial cells are affected
by hypothermic treatment with different mechanisms
and at different rates. Short-term hypothermia applied
immediately after injury reduced hypoxic damage to
axons by supporting the proliferation of oligodendrocyte
progenitors and increasing axonal myelination [26].
Hypothermia also prevents astrogliosis and suppresses
aberrant angiogenesis, which protects the body
from ischemic proliferative retinopathy, a common
complication following hypoxic injury in newborns [27].
Hypothermic treatment has time-dependent effects on
microglial functions that are regulated by several cellular
mechanisms, including neuroinflammation [16,28].
Secondary to in utero hypoxia, there are also several
conditions that directly cause white matter damage during

postnatal periods, including neonatal cardiac surgeries
[29]. HP is an effective treatment for limiting ischemic
injury, but the mechanism is poorly understood. A brief
cycle of HP applied before an ischemia-reperfusion
episode significantly decreased both damage and oxidant
indicators while increasing antioxidant levels in isolated
perfused rat liver [30]. Jiang et al. (2018) showed that the
downregulation of COX-2 expression and the increase
of Na+/K+ ATPase activity increase tolerance to hypoxic
damage and may be associated with the effectiveness of
mild HP at 33 °C [31]. These results show that HP might
be a promising strategy in protecting the brain against
hypoxic damage.
Several studies have shown that chronic neonatal
hypoxia reduced cerebral cortex volume and cell number
and caused a significant suppression in the number of glial
cells located in white matter [32]. In our study, hypoxia
with glucose deprivation caused a significant decrease in
the number of both microglia and astrocytes, especially
after 12 h. However, a mild HP applied before hypoxia
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Figure 2. Cell viability after 12 h of hypoxia with glucose deprivation with or without HP in primary glial cell culture (data are shown as
% of control ± standard error of mean) (n = 3) (*P < 0.05, compared to control; #P > 0.05, ¥P<0.05, compared to HP).

Figure 3. Ferritin-L and -H expression in a) microglia and b) astrocytes in culture after hypoxia with or without HP. Data are shown as
mean ± SEM (n = 3) (*P < 0.05, compared to control; #P < 0.05, compared to HP; ¥P > 0.05, compared to control and HP); c) Ferritin
immunofluorescence staining of astrocytes and microglia in control groups and cells in culture incubated with hypoxia, with or without
HP (20× magnification).
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Figure 4. DMT1 expression in a) microglia and b) astrocytes in culture after hypoxia with or without HP; c) TfR1 and
d) ferroportin expression in microglia and astrocytes in culture after hypoxia with or without HP (*P < 0.05, compared
to control; #P < 0.05, compared to HP, ¥P > 0.05) Data are shown as mean ± SEM (n = 3).

increased the number of microglial cells (P < 0.05) and
provided a protective response against hypoxic effects
in terms of cell viability. Under normal circumstances,
there is a crosstalk between astrocytes and microglia in
CNS, which are together responsible for astrogliosis in
an injured brain. It has previously been shown that not
only resident microglia but also peripherally derived
macrophages travelling to the brain parenchyma after
injury have different effects on neuroinflammation and
regeneration [33]. How this protective effect of HP on
microglia affects astrocytes in in vivo hypoxic conditions
needs to be further investigated.
Hypoxic damage in the brain results in the activation of
a transcription complex, HIF-1a, resulting in the activation
of many genes that will allow cells to adapt to hypoxia
and thus recover from cell death [10]. HIF-1a regulates
the expression of ferritin by binding to a HIF responsive
element upstream of the iron responsive element [34].
We have shown that application of both 6 and 12 h of
hypoxia in cell culture induced significant upregulation in
HIF-1a expression in both microglia and astrocytes when
compared to control.
The proper homeostasis of cellular iron is important
to prevent excess iron overload or iron starvation in cells.
Although it is essential for the activity of various metabolic
enzymes, excessive iron can be harmful via iron-mediated
free radical damage at the molecular level. Impairment

of these properties might lead to dysfunction of iron
metabolism and neurodegeneration in CNS. Glial cells
play a critical role in the regulation of iron homeostasis. A
complex system of interactions involving several transport
and storage proteins, locating both on the cell surface or
intracellularly, could regulate the levels of cellular iron [35].
“Dysregulation of cellular iron homeostasis is considered
to contribute to neural damage in several conditions
including ischemic stroke.” [36] Ryan et al. showed that iron
labeled cells are seen in the lesion along the lesion border at
72 h of medial carotid artery occlusion in mice. At 14 days
of injury, there was a marked elevation in iron-labeled cell
counts throughout the lesion [36]. Another study showed
that in a period of 28 days following spinal cord injury
iron-dextran, treated mice showed increased cellular iron
accumulation at the epicenter of the injury when compared
to vehicle (dextran) control [37]. Glial cells are the main
cells maintaining iron in CNS [24,38]. Zarruk et al. (2015)
showed in experimental autoimmune encephalitis that
iron accumulates in macrophage/microglia but not in
astrocytes [35]. The differences in the expression of iron
import and export proteins in these 2 cell types appear to
underlie the differences in iron accumulation as indicated
above. Increased intracellular iron also alters macrophage
polarization to M1 in the injured spinal cord [37]. In our
study, iron deposition in the cell culture was assessed
histochemically using modified Perl’s histochemistry [22].
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Figure 5. IL-10 and IL-6 levels measured in microglia and astrocyte
cell culture supernatants after hypoxia with or without HP (*P < 0.05,
compared to control; #P < 0.05, compared to HP, ¥P > 0.05). Data are
shown as mean ± SEM (n = 3).

Strong staining of deposition was detected after 12 h of
hypoxia, while 6 h of incubation did not cause a visible
iron accumulation in mixed glial cells. However, in cases
when separately staining microglia and astrocytes, there
was no significant difference between those cells in terms
of iron accumulation (data not shown) at 12 h.
Iron acquisition of the cell takes place in 2 ways
and is defined by the iron transport substrate. In the
nontransferrin bound uptake, ferrous iron (Fe+3)
is reduced to ferric iron (Fe+2) by an endogenous
ferrireductase and transported through the cell membrane

2012

by DMT1. Fe+3 is bound to transferrin in TBI, and this
complex is internalized by endocytosis into the endosome,
then released and reduced to ferric form followed by
transportation into the cytosol [38,39]. Ferritin is the
major iron storage protein, and by accumulating iron in
the cell, it makes it accessible in conditions such as myelin
and enzyme synthesis; it also provides a protective effect in
the development of free iron-mediated oxidative damage
[36]. It has been previously shown that “iron-overload
in neurons increase ferritin to sequester iron in nontoxic
form, to downregulate iron importers and to increase iron
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export.” [40] Each ferritin molecule consists of heavy and
light chain subunits that form a sphere in which iron is
efficiently stored [41]. While ferritin-L is the major storage
form of iron, ferritin-H has ferroxidase activity and could
provide a cytoprotective mechanism in several conditions
such as sickle cell anemia [42]. The ratio of ferritin-L and
-H is tissue specific, and this differential expression may
regulate heme-catalyzed oxidative damage [43]. In our
study, mixed glial cells increased both ferritin -L and -R
expression significantly at 12 h but not so at 6 h of hypoxia.
Cellular distribution and the subcortical white matter
myelinization pattern of ferritin are directly affected by
hypoxia. Brain damage that develops in the neonatal rat
brain mediated by hypoxia-ischemia results in increased
ferritin-positive microglial cells in the environment [13].
Ferritin expression is also indirectly regulated by other
factors such as HIF-1a during hypoxia-reoxygenation.
Ryan et al. showed that there is a significant increase at
the mRNA level of ferritin-L in the ipsilateral hemispheres
in both wild type and ceruloplasmin (an iron exporter)
null mice compared to the contralateral hemispheres after
cerebral artery occlusion. In contrast, mRNA expression
of ferritin-H showed no difference after ischemia in either
genotype, except for a small but significant increase in the
ipsilateral side in ceruloplasmin null mice at 72 h after
ischemia [36]. In our study, hypoxia increased ferritin
expression, both in microglia and astrocytes. However,
HP prevented the accumulation of iron in the cell by
significantly suppressing the expression of ferritin-L.
Although ferritin-H expression also decreased after
hypothermic preconditioning, the difference between
hypoxic conditions was not statistically meaningful.
Considering that mildly decreased temperature does not
have any effect on the increased expression of both chains
of ferritin in astrocytes, it is believed that HP performed
before hypoxia might produce its favorable effects,
especially by decreasing the main iron storage form of
ferritin in microglia.
DMT1 and TfR1are the key proteins that import iron
into the cell. Both proteins play a role in transferrin-bound
and nontransferrin-bound iron uptake and control the cell’s
oxidative stress response by regulating the fenton reaction
[39]. Various studies have evaluated the relationship of
hypoxia and hypoxia reperfusion with the expression of
iron transport proteins and HIF-1a in glial cells, and it
has been found that hypoxia increases the expression of
proteins that release iron from the cell, as well as the proteins
that allow iron to enter the cell [12]. Based on these results,
it has been suggested that hypoxia significantly elevates the
iron transport rate, which in turn may contribute to the
protective mechanism that develops after hypoxia with the
increase in iron levels. Yang et al. suggested that DMT1
and TfR1 induced ferrous uptake under acute hypoxia

[44]. DMT1 regulates microglia polarization, which plays
an important role in determining the regeneration process
after injury [38]. DMT1 facilitates iron export from the
endosome to be utilized by the cell [35,45]. Although
McCarthy et al. have proposed a model in which uptake
of iron is primarily mediated by inflammatory conditions
[38], transcription of the proteins involved in cellular iron
transport is regulated by HIF-1a in many cells, including
astrocytes [11,44] and microglia [12]. In our study, hypoxia
significantly increased the expression of DMT1 and TfR1
in both glial cell types. In contrast, HP specifically induces
DMT1 expression in both cell types but more dramatically
in microglia; it did not have any additional effect on
increased expression of TfR1. The fact that hypoxic damage
increases DMT1 rather than TfR1 suggests that DMT1 is
much more coherently regulated by HIF-1a, as shown
previously by several reports mentioned above. While HP
continues to increase DMT1 in microglia, the suppression
of the expression of both ferritin chains suggests that the
protective effects of HP may be more related to iron traffic,
independent of DMT1.
Ferroportin is a transmembrane protein and the
major iron exporter from the cell. “The discovery of
increased ferroportin expression in response to cellular
iron accumulation is a major break-through in the
understanding of cell survival under conditions of
different iron accumulation [40].” Since ferroportin
expression is also affected by HIF-1a, it has been suggested
that the gene encoding this protein may also be another
hypoxia-induced gene [12,45]. In our study, the increase
of ferroportin levels, which exports iron from the cell,
shows that ferroportin production serves as a protective
mechanism for the removal of iron accumulated in the cell
following hypoxia. In addition, HP continues to increase
ferroportin expression in both microglia and astrocytes
after hypoxia. This increase is significant in astrocytes.
Ferroportin expression increased in both cell types but
only suppressed ferritin-L in microglia, and this shows
that this major exporter protein is mostly sensitive to
the DMT1-related increase of stored iron as ferritin-L.
Since astrocytes, contrary to microglia, do not generate
any significant difference in ferritin levels to hypoxia,
enhanced mobilization of iron may be one of astrocyte’s
self-protective responses to high levels of iron. The fact that
ferritin-H, which is responsible for rapid mobilization of
iron in the cell, changes more clearly due to hypothermia
is another point supporting this argument.
Therapeutic hypothermia may produce its
neuroprotective role by having regulatory effects on
inflammation. In one study, hypothermia and subsequent
reheating caused activation in microglial cells, resulted in
an increase in phagocytosis, and changed cytokine balance
in favor of antiinflammatory cytokines [17]. According to
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Lee et al., hypothermic treatment decreased the expression
of M1 type reactive factors, including proinflammatory
cytokine [46]. The regulatory effect of hypothermia on
inflammation in hypoxic injury is dependent on duration
and severity. Matsui et al. showed that mild hypothermia
reduced the production of TNF-alpha at 6 h and IL-10 and
NO at 48 h after hypoxic injury [47]. There is disagreement
in the literature about whether ferritin has anti- or
proinflammatory effects or whether it is simply a byproduct
of release during inflammation [48]. When focusing on
serum ferritin, the heavy chain has been found mostly to
be responsive to the inflammatory process [49]. Ferritin-H
may facilitate a tolerance mechanism to sepsis [50] and
limit the labile iron from activating the proapoptotic c-Jun
N-terminal kinase (JNK) [51]. In contrast, several studies
show that ferritin can play an antiinflammatory role by
either inhibiting the transcription of proinflammatory
cytokines [52] or by binding to kininogen and reducing
the bradykinin release [53].
In our study, TNF-alpha levels were undetectable
for glial cells in cell culture supernatant. On the other
hand, glial cells increased IL-10 levels after hypoxia
and caused the response developed to be pulled in an
antiinflammatory direction. Hypotermic preconditioning
further increased the hypoxia induced high levels of IL10 in microglia, while there was no significant change
in astrocytes. Microglial cells also increased IL-6 levels
with hypoxia, and HP did not have any effect on this
elevation. IL-6 levels in astrocytes were under detection
limits. IL-6 is a pleiotropic cytokine with pro- but also
antiinflammatory effects [54]. Many inflammatory
factors, as well as neuropeptides and molecules, have been
shown to affect IL-6 regulation in brain cells [55]. While
it is still controversial whether increased iron has proor antiinflammatory effect in the cell, our study suggests
that, in addition to other survival mechanisms, HP may
stimulate an antiinflammatory response, especially in
microglia via ferritin related mechanisms.
Although gene expression is often interpreted in
terms of protein levels, it is well known that change
in mRNA and protein levels does not correlate that
well. The reason for this discussion relies on mainly the
regulation control at different levels. However, there are
also subsets, where change in mRNA expression strongly
correlates with change in protein levels. “The journey
from gene to protein” is tightly controlled within each

cell, and this complex correlation is very much dependent
on the system. In our study, mRNA expression seems to
be almost correlated with ferritin IFA staining. We are
aware of the fact that our study has not any determined
quantitative information regarding the proteins and that
must be further investigated to support our data. Although
our results are based on single cell culture experiments,
it should definitely be kept in mind that glial cells behave
by interacting with each other and under the effect of the
surrounding milieu in CNS. Coculture and in vivo studies
would lead to more beneficial insight in resolving the
hesitation as to whether they contribute to homeostatic or
pathologic processes in the brain.
Our data suggest that HP, which is claimed to be
preventive in hypoxia-induced brain damage, definitely
has a favorable effect on cellular iron homeostasis via
regulation of the storage and transfer proteins of iron.
Ferritin-L, which is well known as the main storage
protein of iron in the cell, plays a major role in this process,
considering that changes in iron homeostasis in glial cells
during ischemia are part of the adaptive response of cells to
hypoxia. We conclude that the resultant iron homeostasis
controlled by HP might present a protective approach
during hypoxic injury. Therefore, further investigation
of in vivo models in which glial cells function as a major
actor of the immune system in CNS may provide a better
understanding of this in the near future.
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